HealthSouth Corporation (HLS) Rating Lowered to Hold at Zacks Investment Research
HealthSouth Corporation (NYSE:HLS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday.
According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. “
Several other research firms have also issued reports on HLS. ValuEngine upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a research report on Friday, July 7th. Royal Bank Of Canada restated a “buy” rating and set a $53.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Piper Jaffray Companies restated a “hold” rating and set a $50.00 price target on shares of HealthSouth Corporation in a research report on Thursday, August 3rd. BidaskClub upgraded shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, Mizuho upped their price target on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research report on Monday, July 10th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $48.83.
Shares of HealthSouth Corporation (NYSE HLS) traded down 0.07% on Tuesday, reaching $44.05. The company had a trading volume of 647,716 shares. The company has a market capitalization of $4.35 billion, a PE ratio of 16.05 and a beta of 0.61. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71. The company’s 50-day moving average is $45.30 and its 200-day moving average is $44.32.
HealthSouth Corporation (NYSE:HLS) last announced its earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million during the quarter, compared to analyst estimates of $976.46 million. During the same period in the previous year, the business earned $0.69 earnings per share. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. Equities research analysts predict that HealthSouth Corporation will post $2.71 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “HealthSouth Corporation (HLS) Rating Lowered to Hold at Zacks Investment Research” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/08/15/healthsouth-corporation-hls-rating-lowered-to-hold-at-zacks-investment-research.html.
In other news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at $12,174,762. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
Several institutional investors have recently modified their holdings of the stock. UBS Asset Management Americas Inc. increased its position in shares of HealthSouth Corporation by 4.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,087 shares of the company’s stock valued at $2,973,000 after buying an additional 2,959 shares during the period. Bank of Montreal Can increased its position in shares of HealthSouth Corporation by 0.7% in the first quarter. Bank of Montreal Can now owns 300,489 shares of the company’s stock valued at $12,864,000 after buying an additional 2,066 shares during the period. Fox Run Management L.L.C. purchased a new position in shares of HealthSouth Corporation during the first quarter valued at approximately $231,000. CWM LLC increased its position in shares of HealthSouth Corporation by 2.1% in the first quarter. CWM LLC now owns 6,384 shares of the company’s stock valued at $273,000 after buying an additional 130 shares during the period. Finally, Louisiana State Employees Retirement System increased its position in shares of HealthSouth Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 22,500 shares of the company’s stock valued at $963,000 after buying an additional 300 shares during the period. 89.79% of the stock is owned by hedge funds and other institutional investors.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.